Recombinant humanized monoclonal antibody to EGFL7.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 148.22 kDa.
Purity
> 91.58% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
EGF-like protein 7, Epidermal growth factor-like protein 7, MEGF7, Multiple EGF-like domains protein 7, Multiple epidermal growth factor-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, VE-statin, Zneu1
SDS-PAGE analysis of Parsatuzumab Biosimilar - Anti-EGFL7 Antibody - Low endotoxin, Azide free (A323650) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Parsatuzumab Biosimilar - Anti-EGFL7 Antibody - Low endotoxin, Azide free (A323650) confirms that the purity of this antibody is 91.58%.
Publishing research using Parsatuzumab Biosimilar - Anti-EGFL7 Antibody - Low endotoxin, Azide free (A323650)? Please let us know so that we can list the citation on this page.
Alternative products to Parsatuzumab Biosimilar - Anti-EGFL7 Antibody - Low endotoxin, Azide free (A323650)
